MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-33-0209887
Vivero Pharmaceuticals Private Limited
Vivero Pharmaceuticals Private Limited - trading in Navi Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹1.33 Cr
▼ 4% YoY
Net profit · FY 2025
₹1.43 Lakh
Net margin 1.1%
EBITDA · FY 2025
₹5.7 Lakh
EBITDA margin 4.3%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹9 Lakh
Issued & subscribed
Open charges
₹7 Lakh
Secured borrowings
Company age
11 yrs
Est. 2015
Directors on board
2
As per MCA filings
About Vivero Pharmaceuticals Private Limited
Data last updated:
Vivero Pharmaceuticals Private Limited is a private limited company based in Navi Mumbai, Maharashtra, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 29 September 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2015PTC268802. Its GSTIN is 27AAFCV3387H1ZY (Maharashtra).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹9 Lakh. It is led by directors Runjhun Kumari and Vimlendu Kumar Ramashankar Mishra.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Office No. 13 Shree Siddhivinayak Co – Op. Society Plot – 26 Sector – 10 Airoli, Navi Mumbai, Maharashtra, India – 400708.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.33 Cr, a decline of 4% compared to the previous year. For the same year it recorded a net profit of ₹1.43 Lakh (net margin 1.1%) and EBITDA of ₹5.7 Lakh (EBITDA margin 4.3%). Revenue has grown at a compounded annual rate (CAGR) of 37% over three years and 32% over five years.
As per MCA filings, the company has open charges of ₹7 Lakh on record.
Vivero Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0209887). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U74999MH2015PTC268802
Registration Number 268802
Incorporation Date 29 September 2015
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MH-33-0209887
Recognitions & Rankings of Vivero Pharmaceuticals
Contact details
Vivero Pharmaceuticals Private Limited's registered office is in Navi Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressOffice No. 13 Shree Siddhivinayak Co – Op. Society Plot – 26 Sector – 10 Airoli, Navi Mumbai, Maharashtra, India – 400708
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of Vivero Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Vivero Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Vivero Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Vivero Pharmaceuticals Private Limited, buy the company report.
Financials of Vivero Pharmaceuticals Private Limited
FY 2025 filings availableVivero Pharmaceuticals Private Limited reported revenue of ₹1.33 Cr (down 4% YoY) for FY 2025.
Revenue · FY 2025
₹1.33 Cr ▼ 4%
Net profit · FY 2025
₹1.43 Lakh margin 1.1%
EBITDA · FY 2025
₹5.7 Lakh margin 4.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 4%
3 years · compounded
▲ 37%
5 years · compounded
▲ 32%
EBITDA CAGR growth
1 year
▲ 45%
3 years · compounded
▲ 3%
5 years · compounded
▲ 23%
Revenue fell 4% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 32%. EBITDA rose 45% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹5.7 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.43 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.3% | ||||
| Net Profit Margin | 1.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Vivero Pharmaceuticals Private Limited, buy the company report.
Board of directors of Vivero Pharmaceuticals Private Limited
Vivero Pharmaceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Runjhun Kumari | Director | 29 Sep 2015 | 11 Years 1 Months | Current |
| Vimlendu Kumar Ramashankar Mishra | Director | 29 Sep 2015 | 11 Years 1 Months | Current |
Auditor
Vivero Pharmaceuticals Private Limited is audited by RAHUL SURESH GAIKWAD for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAHUL SURESH GAIKWAD | FY 2017 | 144414 |
Shareholding
The shareholding of Vivero Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Vivero Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹7 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 06 Mar 2019 | 100251374 | Indian Bank | ₹7 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Vivero Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Vivero Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Vivero Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAFCV3387H1ZY | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Vivero Pharmaceuticals Private Limited, buy the company report.
Recent activity
Vivero Pharmaceuticals Private Limited has 2 board changes on record since 2015: 2 appointments. The latest: Runjhun Kumari was appointed as Director on 29 Sep 2015.
AGM
Vivero Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Vivero Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai Ii.
Charges
A charge with Indian Bank amounted to Rs. 7.00 Lakh with Charge ID 100251374 was registered on 06 Mar 2019.
Appointed
Runjhun Kumari was appointed as Director.
Appointed
Vimlendu Kumar Ramashankar Mishra was appointed as Director.
Incorporation
29 Sep 2015
Vivero Pharmaceuticals Private Limited was registered on 29 Sep 2015 with Roc Mumbai Ii & aged 11 years 1 month as per MCA records.
Frequently asked questions
Vivero Pharmaceuticals is an active private limited company based in Navi Mumbai, Maharashtra, India. The company works in other wholesale, within the trading industry. It was incorporated on 29 September 2015 (11+ years old) and is registered under CIN U74999MH2015PTC268802.
Vivero Pharmaceuticals has 2 current directors:
- Runjhun Kumari - Director
- Vimlendu Kumar Ramashankar Mishra - Director
The latest financial statements of Vivero Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Vivero Pharmaceuticals is 27AAFCV3387H1ZY, registered in Maharashtra.
The CIN (Corporate Identification Number) of Vivero Pharmaceuticals is U74999MH2015PTC268802. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Vivero Pharmaceuticals was incorporated on 29 September 2015, making it 11+ years old. It is registered with the Registrar of Companies, Mumbai.
Runjhun Kumari was appointed as Director on 29 Sep 2015. Vimlendu Kumar Ramashankar Mishra was appointed as Director on 29 Sep 2015.
Yes, Vivero Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-33-0209887).
The registered office of Vivero Pharmaceuticals is at Office No. 13 Shree Siddhivinayak Co – Op. Society Plot – 26 Sector – 10 Airoli, Navi Mumbai, Maharashtra, India – 400708.
Vivero Pharmaceuticals operates in the trading industry, in the other wholesale segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages